| Residential College | false |
| Status | 已發表Published |
| T-MSC，實驗室誕生的準細胞藥 | |
REN-HE XU 
| |
| 2023-07 | |
| Size of Audience | 400 |
| Type of Speaker | Invited speaker |
| Abstract | 徐仁和，澳门大学健康科学学院副院长、特聘教授。徐教授长期从事干细胞研究和治疗应用。他的团队发明的人胚干细胞分化的间充质干细胞（T-MSC）作为研究性新药获得美国FDA批准进入多发性硬化症的临床试验。近期作首席科学家分别获得澳门和科技部国家重点研发项目资助，推进T-MSC治疗糖尿病足、移植物抗寄主病及骨关节炎的临床转化。 |
| Keyword | Pluripotent Stem Cells, Mesenchymal Stem Cells, Therapy |
| Conference Date | 2023-07-08 |
| Conference Place | 珠海市生物医药与大健康产业促进会。珠海 |
| Language | 中文Chinese |
| Document Type | Presentation |
| Collection | Faculty of Health Sciences |
| Affiliation | FHS, University of Macau |
| First Author Affilication | Faculty of Health Sciences |
| Recommended Citation GB/T 7714 | REN-HE XU. T-MSC，實驗室誕生的準細胞藥, 2023-07-08. |
| Files in This Item: | Download All | |||||
| File Name/Size | Publications | Version | Access | License | ||
| 議程.jpeg（381KB） | 会议论文 | 开放获取 | CC BY-NC-SA |  View Download | ||
| File name: | 議程.jpeg |
| Format: | JPEG |
| Resolution: | 1241x1655 |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment